We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




RNAi Engineering May Prevent Mad Cow

By Biotechdaily staff writers
Posted on 31 Mar 2006
By "knocking down” the expression of disease-causing genes in a cloned goat fetus, researchers may have developed a way to prevent bovine spongiform encephalopathy (BSE), known as mad cow disease. More...


The researchers used genetic engineering to produce a goat cell line in which the gene encoding for prion protein (PrP) was targeted for silencing by RNA interference (RNAi). Cells from this line were then used for nuclear transfer to produce a transgenic goat fetus that showed a greater than 90% knock-down of PrP. In earlier studies, silencing the PrP gene in mice made them resistant to prion-mediated diseases, such as BSE. The results of the new research were published in the March 22 issue of the Proceedings of the [U.S.] National Academy of Sciences.

The same technology may be able to be used in cattle to prevent mad cow and other serious diseases, according to the researcher team, whose members are from Texas A&M's College of Veterinary Medicine & Biomedical Sciences (College Station, TX, USA) and the Howard Hughes Medical Institute's Cold Spring Harbor Laboratory (Cold Spring Harbor, NY, USA).

BSE is a fatal brain-wasting disease, first identified in 1986. It affects a cow's nervous system and causes the animal to lose much of its movement before it eventually dies. More than 180,000 cases of BSE have been confirmed worldwide, including recent cases in the United States. The disease can be passed to humans, and more than 100 such cases have been confirmed, most of those in the United Kingdom.

"The next step is to try and avoid the cloning process--to skip that process if possible in developing the disease-resistant animals,” explained Dr. Mark Westhusin, one of the researchers. "That's where more research is going to be needed and where the process goes from here.” Dr. Westhusin has been involved in several cloning "firsts,” including the cloning of a cat in 2002 and a white-tailed deer in 2004.



Related Links:
Texas A&M
HH Medical Institute's Cold Spring Harbor

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Electrolyte Analyzer
BKE-B
Automated Clinical Chemistry Analyzer
Envoy 500+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

New Insights Into Fetal DNA Could Improve Non-Invasive Prenatal Testing

Non-invasive prenatal testing is widely used to screen pregnancies for genetic conditions by analyzing DNA fragments in maternal blood. Although it offers a safer alternative to invasive procedures such... Read more

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.